Target Product Profiles
The Blueprint for Your Minimum Viable Product (MVP).
If you don’t know where you’re going, how do you get there? The same logic applies in drug development: if you don’t know the characteristics of the drug you want to design, how can you build it?
What Is a Target Product Profile (TPP)?
A TPP outlines the characteristics of the drug or platform you intend to develop. During early drug development, your TPP describes the minimum viable product that is suitable for patients or customers. It includes the disease or disorder the drug is intended to treat, the patient population, mechanism of action (MoA), efficacy and safety profiles, and route of administration. These attributes support the design of experimental workflows, so your team remains laser-focused on directing resources where they matter most.
Like fine wine that must age to reach maturity, a TPP becomes more refined as you generate more data and gain further insights about your target patient population. It begins as a concept that matures into a development navigation tool.
Anatomy of a TPP
What a TPP Looks Like
Every characteristic built into your product likely requires its own workflow to achieve. The sheet below is illustrative. Your TPP is built around your candidate.
Target Product Profile
Example
Document Version
v0.1 draft
- Modality
Small molecule
- Indication
Amyotrophic lateral sclerosis (ALS)
- Patient Population
Adults with ALS; no genetic or subtype restriction
- Mechanism of Action
Binds SOD1 mRNA, causing degradation and reducing SOD1 protein synthesis
- Route of Administration
IV infusion
- Efficacy
High ALSFRS-R to week 28 vs. Tofersen
- Safety / Tolerability
Adverse effects (AEs) ~7% vs. Tofersen
Why Are TPPs So Valuable?
Simply put, they save time and money. Teams lacking a TPP tend to make decisions in silos. Preclinical development is developing one target while manufacturing and clinical are preparing for another. Constraints appear too late. The result is a misaligned program that wastes time and capital.
No Ambiguity
Forces explicit choices. Every stakeholder has the same information to execute their tasks.
Sets Go/No-Go Criteria
Defines the thresholds that determine whether your program advances or pivots.
Simplifies Planning
One document aligns all functions around a single, achievable vision of success.
Sharpens Investor Narrative
Investors fund clarity. Show them you know what you are developing and its potential patient impact.
Living Document
TPPs mature as new evidence emerges and is refined with every development milestone.
Key Components of a TPP
Six characteristics anchor early-stage drug and platform developments. As development progresses, elements are expanded and refined.
Modality
Product
Indication
Purpose
Patient Population
Customers
Route of Administration
Efficacy
Safety & Tolerability
Frequently Asked Questions
Define Your Product's Journey
Whether you are building your first TPP or refining an existing profile, we can help you build a solid foundation to move progress forward.
Book a Free Strategy Call